risankizumab (Skyrizi) Report issue

Biologics mAb Approved FDA
AACT
Back

Drug Pricing Summary

AUS PBS

$2051.9981

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
risankizumab 75 mg / 0.83 mL (INJECTION) $2051.9981 AUS PBS generic
  • Skyrizi (2)
    		•  AbbVie Pty Ltd

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue